← FDA Drug Approvals (Drugs@FDA)

EPTIFIBATIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2024-05-09

Drug application

FDA Application #
ANDA213599
Application type
Abbreviated New Drug Application (Generic)
Brand name
EPTIFIBATIDE
Generic name
EPTIFIBATIDE
Active ingredients
EPTIFIBATIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
MEITHEAL
Manufacturer
Meitheal Pharmaceuticals Inc.
First approval
2024-05-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown